Viruses Treatment Articles

Katharine Spink, Malcolm Moos, And David Schaffer To Present At Advances In Stem Cell Discovery And Development Conference, San Francisco, Oct. 20-22

April 04, 2017

Katharine Spink, Ph.D., Vice President of Operations for Geron's Regenerative Medicine Programs; Malcolm Moos Jr., M.D., Ph.D., Medical Officer, at FDA/CBER/OCTGT; and David Schaffer, Professor of Chemical Engineering, Bioengineering, and Neuroscience at University of California, and Co-Director of the Berkeley Stem Cell Center will give a featured presentations at the 4th Advances in Stem Cell Discovery and Development Conference to be held this year in San Francisco, CA Oct. 20-22, 2010 by GTCbio. This conference will address recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, stem cell reprogramming, FDA and NIH policies regarding funding for stem cell research, and private funding from the pharmaceutical industry.

Also presenting at the Advances in Stem Cell Discovery and Development Conference are prestigious organizations including Fate Therapeutics, California Institute for Regenerative Medicine (CIRM), Geron, Stanford, UCB, City of Hope Medical Center, Cellartis AB, UCSF, Proteus Venture Partners, Sanofi-Aventis, UCSB, Aldagen, University of the Pacific, Novo Nordisk, The Salk Institute for Biological Studies, UCSD, Sangamo, Merck, Advanced Cell Technology and other leaders in the Stem Cell Discovery and Development industry.

4th Advances in Stem Cell Discovery and Development Conference features a mixture of academic, industry and public sector experts in an intimate setting that favors the showcase of data, the exchanges of ideas and networking. Professionals in the drug discovery industry and academics to can get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery and development process to improve the efficiency and output.

The conference will be part of the 6th Modern Drug Discovery and Development Summit which will offer an in-depth examination of the challenges involved in the dynamic and ever-changing field of drug discovery and development. This summit includes a plenary keynote presentation and four concurrent tracks on: 4th Advances in Stem Cell Discovery and Development, 5th Biological Therapeutics Research and Development, 2nd Cancer Targets and Therapeutics and 4th Biomarker Discovery and Development. It will bring researchers, lab directors/managers, and industry executives the critical scientific, technology, and business coverage that they need.

Author:
GTCbio

Source:
GTCbio
434 W. Foothill Blvd. Monrovia, CA 91016
Tel: (626) 256-6405
fax: (626) 256-6460
email: infogtcbiogtcbio

Company Website

Event Website